Literature DB >> 16166434

Expression of thrombospondin-1 in resected colorectal liver metastases predicts poor prognosis.

Christopher D Sutton1, Kenneth O'Byrne, Jonathan C Goddard, Leslie-Jayne Marshall, Louise Jones, Giuseppe Garcea, Ashley R Dennison, Graham Poston, David M Lloyd, David P Berry.   

Abstract

PURPOSE: The aim of this study was to examine the expression and prognostic relevance of thrombospondin-1 (TSP-1) in tumor biopsies taken from a consecutive series of liver resections done at the University Hospitals of Leicester and the Royal Liverpool Hospital. EXPERIMENTAL
DESIGN: Patients having undergone a liver resection for colorectal liver metastases at our institutions between 1993 and 1999 inclusive were eligible. Inclusion criteria were curative intent, sufficient tumor biopsy, and patient follow-up data. One hundred eighty-two patients were considered in this study. Standard immunohistochemical techniques were used to study the expression of TSP-1 in 5-microm tumor sections from paraffin-embedded tissue blocks. TSP-1 was correlated with survival using the Kaplan-Meier method and log-rank test for univariate analysis and the Cox proportional hazard model for multivariate analysis.
RESULTS: One hundred eighty-two patients (male, n = 122 and female, n = 60) ages between 25 and 81 years (mean, 61 years) were included. TSP-1 was expressed around blood vessels (n = 45, 25%) or in the stroma (n = 59, 33%). No expression was detected in the remaining tumors. TSP-1 significantly correlated with poor survival on univariate (P = 0.01 for perivascular expression and P = 0.03 for stromal expression) and multivariate analysis (P = 0.01 for perivascular expression).
CONCLUSION: TSP-1 is a negatively prognostic factor for survival in resected colorectal liver metastases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166434     DOI: 10.1158/1078-0432.CCR-05-0439

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  13 in total

1.  Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival.

Authors:  Haruhisa Kitano; Shun-Ichiro Kageyama; Stephen M Hewitt; Ryuji Hayashi; Yoshinori Doki; Yoshitomo Ozaki; Shozo Fujino; Mikiko Takikita; Hajime Kubo; Junya Fukuoka
Journal:  Arch Pathol Lab Med       Date:  2010-10       Impact factor: 5.534

Review 2.  Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Authors:  Jeff S Isenberg; Gema Martin-Manso; Justin B Maxhimer; David D Roberts
Journal:  Nat Rev Cancer       Date:  2009-02-05       Impact factor: 60.716

3.  Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.

Authors:  Jorge Barriuso; Raghavendar T Nagaraju; Shreya Belgamwar; Bipasha Chakrabarty; George J Burghel; Helene Schlecht; Lucy Foster; Elaine Kilgour; Andrew J Wallace; Michael Braun; Caroline Dive; D Gareth Evans; Robert G Bristow; Mark P Saunders; Sarah T O'Dwyer; Omer Aziz
Journal:  Clin Cancer Res       Date:  2020-11-30       Impact factor: 12.531

Review 4.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

5.  Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.

Authors:  Seung-Beom Hong; HyoungBin Oh; Vladimir A Valera; Jaime Stull; Duy-Tan Ngo; Masaya Baba; Maria J Merino; W Marston Linehan; Laura S Schmidt
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

6.  Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.

Authors:  F Loupakis; C Cremolini; A Fioravanti; P Orlandi; L Salvatore; G Masi; T Di Desidero; B Canu; M Schirripa; P Frumento; A Di Paolo; R Danesi; A Falcone; G Bocci
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

Review 7.  Cell surface markers in colorectal cancer prognosis.

Authors:  Larissa Belov; Jerry Zhou; Richard I Christopherson
Journal:  Int J Mol Sci       Date:  2010-12-28       Impact factor: 5.923

8.  Constitutive and Inducible Expression of Invasion-related Factors in PC-3 Prostate Cancer Cells.

Authors:  Young Sun Hwang; Paul F Lindholm
Journal:  J Cancer Prev       Date:  2015-06

9.  Identification of TAX2 peptide as a new unpredicted anti-cancer agent.

Authors:  Albin Jeanne; Emilie Sick; Jérôme Devy; Nicolas Floquet; Nicolas Belloy; Louis Theret; Camille Boulagnon-Rombi; Marie-Danièle Diebold; Manuel Dauchez; Laurent Martiny; Christophe Schneider; Stéphane Dedieu
Journal:  Oncotarget       Date:  2015-07-20

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.